Archives
-
Pregnenolone Carbonitrile in the Gut–Liver Axis
2026-09-24
Pregnenolone Carbonitrile is more than a tool for studying CYP3A induction: new mouse research connects PXR activation with microbiota-dependent YAP signaling during sepsis-associated liver injury. Learn what this finding means for model selection, controls, and interpreting hepatic protection.
-
mCherry mRNA for LNP Delivery Assays
2026-09-24
Use red fluorescent protein mRNA to test whether a delivery workflow produces functional protein expression—not merely whether particles contact cells. This practical guide pairs EZ Cap™ mCherry mRNA with an LNP-focused fibroblast use case, while separating reporter readouts from the evidence needed to confirm gene editing.
-
MK-5108 (VX-689) Aurora-A Research Workflows
2026-09-23
Use MK-5108 (VX-689) to connect Aurora-A target engagement with cell-cycle and tumor-growth readouts, while keeping biochemical potency separate from cellular dose selection. This workflow adapts retinoblastoma findings into practical experiments and highlights controls for selectivity, solvent effects, and assay interpretation.
-
Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO)
2026-09-23
This EDTA-free Protease Inhibitor Cocktail helps limit proteolysis during protein extraction and downstream assays while avoiding added EDTA that can disrupt divalent-cation-sensitive workflows. It is suitable for Western blotting, co-immunoprecipitation, phosphorylation analysis, and related applications, but it should not be treated as a complete solution for metalloprotease inhibition or used without checking DMSO and assay compatibility.
-
hiPSC-Derived Intestinal Organoids for Pharmacokinetics
2026-09-22
A 2025 study established a direct three-dimensional culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. The organoids could be propagated, cryopreserved, and differentiated into intestinal epithelial cells with enterocyte-associated drug-metabolizing enzyme and transporter activities, offering a more human-relevant platform for pharmacokinetic research.
-
Sulfaphenazole Derivatives Against M. tuberculosis
2026-09-22
Chen and colleagues optimized sulfaphenazole-derived sulfonamides to preserve antimycobacterial activity while reducing CYP 2C9 inhibition. Compound 10d was the leading example, combining a reported MIC of 5.69 μg/mL with CYP 2C9 inhibition weaker than 10 μM, although further pharmacological validation is required.
-
BAPTA-AM: Calcium Chelation for Neurotoxicity Assays
2026-09-21
BAPTA-AM is a cell-permeable calcium chelator for testing whether intracellular Ca2+ is a cause, consequence, or amplifier of cellular injury. This guide translates recent neurotoxicity findings into practical workflows for calcium imaging, apoptosis assays, and mechanistic pathway validation.
-
Ethacridine Lactate Monohydrate in Ectoderm Assays
2026-09-21
Ethacridine lactate monohydrate can support contamination-conscious biochemical research without being mistaken for a validated stem-cell differentiation reagent. This guide connects microbial-control decisions with the YAP–TEAD super-enhancer framework and explains the controls needed to protect epigenetic assay interpretation.
-
Pregnenolone Carbonitrile in Gut–Liver Studies
2026-09-20
Pregnenolone Carbonitrile is more than a rodent PXR agonist for xenobiotic metabolism research. This article explains how PCN can be used to separate direct hepatic signaling from gut microbiota-dependent protection in sepsis and fibrosis-oriented assay design.
-
Endogenous Melatonin in LPS-Activated Macrophages
2026-09-19
The reference study identifies an endogenous feedback mechanism in which LPS activates Aanat transcription through the TLR4/TRIF/IRF3 axis, increasing macrophage melatonin production during M1-like polarization. Its findings suggest that locally produced melatonin restrains inflammatory polarization, oxidative stress, and apoptosis, providing a mechanistic view of macrophage self-protection during innate immune activation.
-
CGRP Restraint of CD4+ T Cells in Allergy
2026-09-18
Li et al. identify a sensory-neuroimmune checkpoint in which CGRP signaling through RAMP1 directly restrains CD4+ T-cell activation, differentiation, and Tfh accumulation during house dust mite sensitization. Their combined imaging, genetic, adoptive-transfer, TCR-sequencing, and epigenomic approach links reduced CGRP innervation with stronger allergic sensitization and shows that CGRP treatment can lessen experimental asthma during the sensitization phase.
-
(-)-Arctigenin Workflow for MEK1 Inhibitor Studies
2026-09-18
Build a practical breast-cancer microenvironment workflow around (-)-Arctigenin, combining NF-κB, iNOS, MEK1, extracellular-vesicle, and invasion readouts. The approach distinguishes validated product properties from exploratory assay recommendations so researchers can test pathway modulation without overstating evidence.
-
SAR131675: Translational Control of VEGFR-3
2026-09-17
A mechanistic and strategic guide to using SAR131675 as a selective VEGFR-3 inhibitor for dissecting lymphangiogenesis, angiogenesis, and tumor biology while accounting for formulation constraints and discontinued development.
-
miR-196a Drives Esophageal Adenocarcinoma Aggressiveness
2026-09-17
The reference study identifies a mechanistic link between miR-196a overexpression and aggressive esophageal adenocarcinoma through coordinated activation of the MYC/TERT/NFκB axis. Its combination of miRNA perturbation, EMT and motility assays, pathway inhibition, and Barrett’s esophagus tissue analysis provides a framework for distinguishing progression markers from functional drivers.
-
DMG-PEG2000-NH2 for LNP Linker Design
2026-09-16
DMG-PEG2000-NH2 is an NH2-PEG derivative designed for amide coupling to carboxyl-containing biomolecules and lipid-based delivery workflows. Its documented molecular weight, solvent solubility, purity, and −20 °C storage requirement support reagent selection, while actual liposome, LNP, and siRNA performance requires independent validation.